Mitral annulus calcification (MAC) is a chronic, degenerative process in the fibrous base of the mitral valve. Although MAC was initially thought to be an age-related degenerative process, there is accumulating evidence that other mechanisms, such as atherosclerosis and abnormal calcium-phosphorus metabolism, also contribute to the development of MAC.
M
itral annulus calcification (MAC) is a chronic, degenerative process of the fibrous support structure of the mitral valve (1, 2) . The reported prevalence of MAC is between 8% and 15%, but it significantly increases with age and in patients with multiple cardiovascular risk factors or chronic kidney disease (CKD) (3) (4) (5) (6) (7) .
Although calcification of the mitral annulus was initially thought to be an age-related process, there is accumulating evidence that it is a tightly regulated, active process, with features similar to both medial and atherosclerotic cardiovascular calcification (8) .
Its clinical relevance comes from MAC's association with an increased rate of mortality and cardiovascular disease (CVD) (9) . MAC has also been found to increase the incidence of mitral valve disease and arrhythmias and to influence the outcome of cardiac surgery (2, 10, 11) . We reviewed the available published data to seek: 1) a consistent, clinically relevant definition of MAC on the basis of contemporary imaging; 2) a firm understanding of its pathogenesis and associations; and 3) the clinical implications of this disease entity.
DEFINITION AND DIAGNOSIS
The mitral annulus separates the left atrium from the left ventricle (LV). It has a complex saddle shape that is divided into anterior and posterior portions. The anterior annulus spans the left and right fibrous trigones and is anatomically coupled to the aortic annulus. The posterior annulus encompasses the remainder of the annular perimeter and is composed of a discontinuous rim of fibrous tissue periodically interrupted by fat (12) . MAC is defined as a chronic degenerative process in the fibrous base of the mitral valve (1, 2, 13) . In 1910, Dewitzky recognized noninflammatory calcific disease of the mitral annulus fibrosus as an entity, presented a detailed pathological description of 36 cases, and likened the lesion to a similar process in the aortic valve described by Mönckeberg in 1904 (1) . Large historical autopsy studies found MAC in approximately 10% of patients (3, 14) . MAC more commonly affects the posterior annulus than the anterior annulus (15, 16) . was assessed by M-mode echocardiography and defined as an echo-dense band visualized throughout systole and diastole, distinguishable from the posterior mitral valve leaflet, and located anterior and parallel to the posterior LV wall (9) . In the Cardiovascular Health Study, MAC was defined by an intense echocardiograph-producing structure located at the junction of the atrioventricular groove and posterior mitral leaflet (19) . Severity was qualitatively determined in parasternal short-axis view at the level of the mitral annulus as mild (focal, limited increase in echodensity of the mitral annulus), moderate (marked echodensity involving one-third to one-half of the ring circumference), or severe (marked echodensity involving more than one-half of the circumference of the ring or with intrusion into the LV inflow tract). Maximal MAC thickness measured from the anterior to the posterior edge at its greatest width is also used to assess MAC severity, with a value >4 mm defining severe MAC (20) . Many studies have shown a strong association between MAC and cardiovascular risk factors (5, 17, 25) .
A strong correlation was also demonstrated between MAC and aortic atheroma, carotid atherosclerotic disease, peripheral artery disease, and CAD (17, 19) .
These studies further support the hypothesis that calcification of the mitral annulus is strongly associated with the pathogenesis of atherosclerosis. MAC is a common finding in patients with CKD. This association may be partially explained by an increased prevalence and severity of cardiovascular risk factors and atherosclerotic disease in these patients (30) . Nonetheless, there is growing evidence that the abnormal calcium-phosphorus metabolism observed in patients with chronic renal failure has a direct role in the pathogenesis of MAC (2, 26, 31) .
CONGENITAL METABOLIC DISORDERS ASSOCIATED
WITH MAC. M a r f a n s y n d r o m e . In the past, MAC at <40 years of age was considered a minor diagnostic criterion for Marfan syndrome (32) . Aortic root dilation and MVP are common cardiovascular features of this disease (33) . It remains unclear whether the mitral annulus calcifies because of increased mitral stress caused by MVP or due to an intrinsic abnormality of the connective tissue composing the annulus. Abramowitz et al. 
CLINICAL IMPLICATIONS
MAC is usually an incidental finding in patients being evaluated for cardiovascular or pulmonary diseases.
The presence of a calcified mitral annulus is asymptomatic, which precludes true evaluation of the prevalence of MAC in the general population. In large historical autopsy studies, MAC was found in approximately 10% of patients (3, 14) . CT scans or echocardiography assessments of MAC without defining its severity revealed calcification in 8% to 15% of patients without known CVD (4, 5, 7, 9) . The prevalence of MAC was 42% in elderly patients with known CVD (19 
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